Dong‐Hao Wu

764 total citations
35 papers, 548 citations indexed

About

Dong‐Hao Wu is a scholar working on Oncology, Hepatology and Cancer Research. According to data from OpenAlex, Dong‐Hao Wu has authored 35 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Hepatology and 11 papers in Cancer Research. Recurrent topics in Dong‐Hao Wu's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers) and Cancer, Lipids, and Metabolism (8 papers). Dong‐Hao Wu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers) and Cancer, Lipids, and Metabolism (8 papers). Dong‐Hao Wu collaborates with scholars based in China, Germany and United States. Dong‐Hao Wu's co-authors include Xiaokun Ma, Qu Lin, Zhan‐Hong Chen, Dan‐Yun Ruan, Jing‐Yun Wen, Xing Li, Min Dong, Xiangyuan Wu, Yan‐Fang Xing and Tiantian Wang and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and International Journal of Biological Macromolecules.

In The Last Decade

Dong‐Hao Wu

30 papers receiving 542 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dong‐Hao Wu 259 192 172 165 116 35 548
Tomonari Shimagaki 120 0.5× 113 0.6× 170 1.0× 142 0.9× 112 1.0× 47 467
Federico Piñero 131 0.5× 248 1.3× 310 1.8× 176 1.1× 239 2.1× 38 712
Oxana V. Makarova‐Rusher 334 1.3× 232 1.2× 269 1.6× 116 0.7× 133 1.1× 17 707
Guo Long 170 0.7× 94 0.5× 91 0.5× 165 1.0× 213 1.8× 26 492
Zi‐Niu Ding 179 0.7× 112 0.6× 110 0.6× 75 0.5× 72 0.6× 45 391
J. Moschandrea 171 0.7× 234 1.2× 219 1.3× 65 0.4× 78 0.7× 13 548
Rumi Matono 206 0.8× 114 0.6× 192 1.1× 78 0.5× 81 0.7× 24 591
E Popa 238 0.9× 81 0.4× 298 1.7× 101 0.6× 191 1.6× 28 682
Annalisa Ardiri 127 0.5× 213 1.1× 335 1.9× 101 0.6× 112 1.0× 19 639
Norifumi Iseda 171 0.7× 56 0.3× 104 0.6× 180 1.1× 147 1.3× 54 498

Countries citing papers authored by Dong‐Hao Wu

Since Specialization
Citations

This map shows the geographic impact of Dong‐Hao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Hao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Hao Wu more than expected).

Fields of papers citing papers by Dong‐Hao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Hao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Hao Wu. The network helps show where Dong‐Hao Wu may publish in the future.

Co-authorship network of co-authors of Dong‐Hao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Hao Wu. A scholar is included among the top collaborators of Dong‐Hao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Hao Wu. Dong‐Hao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Dong‐Hao, et al.. (2024). Single-cell and machine learning approaches uncover intrinsic immune-evasion genes in the prognosis of hepatocellular carcinoma. Liver Research. 8(4). 282–294. 4 indexed citations
3.
Chen, Xianyu, Dong‐Hao Wu, Ruixi Li, et al.. (2023). From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinoma. Frontiers in Oncology. 13. 1278467–1278467. 10 indexed citations
4.
Wang, Tian-tian, Zhan‐Hong Chen, Dong‐Hao Wu, et al.. (2021). Synergistic effects of α-Mangostin and sorafenib in hepatocellular carcinoma: New insights into α-mangostin cytotoxicity. Biochemical and Biophysical Research Communications. 558. 14–21. 6 indexed citations
5.
6.
Li, Wei, Jing‐Yun Wen, Jie Chen, et al.. (2019). Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer. World Journal of Gastroenterology. 25(37). 5590–5603. 29 indexed citations
7.
8.
Chen, Zhan‐Hong, Xing Li, Dong‐Hao Wu, et al.. (2017). Validation and ranking of seven staging systems of hepatocellular carcinoma. Oncology Letters. 14(1). 705–714. 21 indexed citations
9.
Lin, Qu, Xing Li, Xiaokun Ma, et al.. (2017). Prognostic significance of preoperative albumin-to-globulin ratio in patients with cholangiocarcinoma. Current Research in Translational Medicine. 65(2). 83–87. 11 indexed citations
10.
Wu, Dong‐Hao, Tiantian Wang, Dan‐Yun Ruan, et al.. (2017). Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 97. 195–202. 32 indexed citations
11.
Chen, Zhan‐Hong, Wei Li, Xiaokun Ma, et al.. (2017). Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma. Oncology Letters. 14(2). 2089–2096. 24 indexed citations
12.
Li, Xing, Xiang Zhong, Zhan‐Hong Chen, et al.. (2016). Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization. Asian Pacific Journal of Cancer Prevention. 16(18). 8665–8670. 10 indexed citations
13.
14.
Chen, Zhan‐Hong, Xiaokun Ma, Xing Li, et al.. (2015). Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma. Tumor Biology. 37(4). 5265–5273. 5 indexed citations
15.
Wang, Tiantian, Xing Li, Min Dong, et al.. (2015). MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells. Oncology Letters. 10(5). 2691–2698. 25 indexed citations
16.
Wu, Dong‐Hao, Changchang Jia, Jie Chen, et al.. (2014). Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma. Tumor Biology. 35(12). 12225–12233. 77 indexed citations
17.
Li, Xing, Zhan‐Hong Chen, Yan‐Fang Xing, et al.. (2014). Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumor Biology. 36(4). 2263–2269. 91 indexed citations
18.
Li, Xing, Xiang Zhong, Zhan‐Hong Chen, et al.. (2014). Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients. Asian Pacific Journal of Cancer Prevention. 15(22). 9635–9641. 11 indexed citations
19.
Lin, Qu, Dong‐Hao Wu, Xiang-yuan Wu, et al.. (2014). A comparison of dioctahedral smectite and iodine glycerin cream with topical mouth rinse in treatment of chemotherapy induced oral mucositis: A pilot study. European Journal of Oncology Nursing. 19(2). 136–141. 14 indexed citations
20.
Li, Xing, Zhan‐Hong Chen, Xiaokun Ma, et al.. (2014). Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumor Biology. 35(11). 11057–11063. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomonari Shimagaki Breakdown of academic impact, for papers by Federico Piñero Breakdown of academic impact, for papers by Oxana V. Makarova‐Rusher Breakdown of academic impact, for papers by Guo Long Breakdown of academic impact, for papers by Zi‐Niu Ding Breakdown of academic impact, for papers by J. Moschandrea Breakdown of academic impact, for papers by Rumi Matono Breakdown of academic impact, for papers by E Popa Breakdown of academic impact, for papers by Annalisa Ardiri Breakdown of academic impact, for papers by Norifumi Iseda
Rankless by CCL
2026